Novozymes and
Chr. Hansen to combine
and create a leading global biosolutions partner
Key documents
Announcements
Stock exchange announcement
Press release
Presentation
Investor presentation
Conference call
Merger documents
Merger plan
Merger statement
Tax-exempt merger ruling
Auditor documents
Valuer’s report on the merger plan
Valuer’s report on the creditors’ position after merger
FAQ
Factsheet
Contacts
Investor relations
Tobias Cornelius Björklund
Head of Investor relations
+45 3077 8682
tobb@novozymes.com